EP0028815A2
Expired / Lapsed
EP
⏱️ 0.0 years remaining
The use of ricin and a pharmaceutical composition containing the same for increasing the immune response
Assignee: Eisai Co Ltd
•
Filing: 1980-11-06
•
Granted: —
•
Expires: 2000-11-06
Abstract
Abstract An immunopotentiator comprising ricin as an active ingredient. Ricin is a glucoprotein having a molecular weight of about 65,000 and can be used in the form of an injectable solution. It is useful for prevention and treatment of bacterial and viral infections and cancer.
Inventors
- 👤 Hiroshi Shionoya
- 👤 Haruyoshi Arai
- 👤 Nozomu Koyanagi
- 👤 Hitoshi Takeuchi
Bibliographic Details
Application Number
—
Jurisdiction
EP
Data Source
google_patents
Last Synchronized
2026-11-07 10:58
CPC Classifications
A; A61; A61K; A61K39/00; A61K39/39; A61K38/00; A61K38/16; A61K38/168; A61P; A61P31/00; A61P31/04; A61P35/00; A61P37/00; A61P37/02; A61P37/04; A61K2039/555; A61K2039/55511; A61K2039/55516
Claims Analysis
Total Claims: 9
Claim 1
Independent Claim
8 words
An immunopotentiator comprising ricin as an active ingredient.
Claim 2
Dependent Claim
8 words
An immunopotentiator comprising ricin as an active ingredient.
Claim 3
Dependent Claim
12 words
An injectable preparation comprising ricin, an antigen and a pharmaceutically acceptable diluent.
Claim 4
Dependent Claim
12 words
An injectable preparation comprising ricin, an antigen and a pharmaceutically acceptable diluent.
Claim 5
Dependent Claim
10 words
The preparation of Claim 2 wherein the diluent is water.
Claim 6
Independent Claim
20 words
A method for preventing or treating microbial infections or cancer, which comprises administering ricin to a human or animal subject.
Claim 7
Independent Claim
20 words
A method for preventing or treating microbial infections or cancer, which comprises administering ricin to a human or animal subject.
Claim 8
Dependent Claim
21 words
The method of Claim 4 wherein the dose of ricin is at least about 0.2 ng per human or animal subject.
Claim 9
Dependent Claim
28 words
The method of Claim 4 or 5 wherein the dose of ricin is up to about 1.5 µg/kg of the body weight of the human or animal subject.
References Cited (Backward Citations)
No citation records indexed.
USPTO Annuity & Maintenance Windows
Maintenance schedule is calculated for granted US utility patents.